Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
980.3 DKK | +1.34% | +0.65% | +40.42% |
Jul. 12 | Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market | RE |
Jul. 12 | Ozempic linked with lower dementia risk, nicotine use, British study finds | RE |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.42% | 636B | |
+62.66% | 854B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B | |
+0.45% | 164B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- Transcript : Novo Nordisk A/S Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-12-2021 06